Therapy Reduces Chances of Dialysis

March 17, 2015

(Economic Times) – A research led by scientists of the Monash University has for the first time shown the effectiveness of combining a stem cell-based therapy with an anti-scarring agent which would reverse scarring and markers of kidney injury, thereby reducing the need for dialysis or transplantation. The researchers discovered that adult stem cells when combined with a protein called serelaxin, could reverse scarring.